We are live on ! Find out more
LIVN icon

LivaNova

203 hedge funds and large institutions have $3.44B invested in LivaNova in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 85 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 29

10% more capital invested

Capital invested by funds: $3.13B → $3.44B (+$313M)

0.81% more ownership

Funds ownership: 95.35%96.16% (+0.81%)

0% more funds holding

Funds holding: 203203 (0)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

36% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 85

60% less call options, than puts

Call options by funds: $3.69M | Put options by funds: $9.13M

Holders
203
Holders Change
Holders Change %
0%
% of All Funds
3.56%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
32
Increased
54
Reduced
85
Closed
29
Calls
$3.69M
Puts
$9.13M
Net Calls
-$5.43M
Net Calls Change
-$6.14M

LIVN Hedge Fund Activity: Q1 2021 in Review

203 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in LivaNova (LIVN) for Q1 2021, worth a combined $3.44B — up 10% from $3.13B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new LIVN positions and 29 closed out — a net gain of 3 holders — while 54 added to existing stakes and 85 trimmed.

The largest buyer was Eminence Capital, opening a new position worth an estimated $99.4M. The largest seller was HealthCor Management, exiting entirely with an estimated $40.8M sold.

  • 203 institutional investors held LivaNova (LIVN) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $3.44B of LivaNova stock for Q1 2021, up 10% quarter-over-quarter.
  • 32 funds opened new LivaNova positions in Q1 2021 and 29 closed out, a net change of +3 holders.
  • The largest LivaNova buyer in Q1 2021 was Eminence Capital, an estimated $99.4M added.
  • The largest LivaNova seller in Q1 2021 was HealthCor Management, an estimated $40.8M sold.

Based on aggregated 13F filings for Q1 2021.